Vol. 62 No. 1s1 (2021)

Published May 13, 2021

https://doi.org/10.15167/2421-4248/jpmh2021.62.1s1

Health Technology Assessment (HTA) sull’introduzione di coorti aggiuntive per la vaccinazione contro il meningococco con vaccini quadrivalenti coniugati in Italia

"Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy"

Full Issue

PDF

Health Technology Assessment (HTA) sull’introduzione di coorti aggiuntive per la vaccinazione contro il meningococco con vaccini quadrivalenti coniugati in Italia: "Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy"

https://doi.org/10.15167/2421-4248/jpmh2021.62.1s1.2140